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I STILL HAVEN’T FOUND WHAT I’M LOOKING FOR,1 BUT I MAY HAVE 
FOUND SOMETHING ELSE: NON-PHYSICIAN RESEARCHERS AND 
INCIDENTAL FINDINGS IN MAGNETIC RESONANCE IMAGING 
INTRODUCTION 
Brain scans performed on symptomatic patients may serve a diagnostic 
function, enabling a clinician to locate the cause of a problem.2  Magnetic 
resonance imaging (MRI) could help to diagnose a tumor or elucidate the 
cause of headaches, changes in vision, sensation, or cognition.3  In stark 
contrast, brain scans performed on asymptomatic volunteers in a cognition 
study, for example, may be the source of problems for both the principal 
investigator and the research participant.  Instead of contributing to 
generalizable data, the scan may reveal a serious problem.  These 
accidental discoveries can have potentially life-changing effects.  In one 
case, a medical student was alerted to an arteriovenous malformation 
during an fMRI study on memory.4  After successful surgeries, she was 
“transformed by this experience as a patient and a student.”5  In another 
case, a self-professed “neuro-nerd” eagerly volunteered for an MRI study, 
curious to see images of his own brain.6  The opportunity ended up having 
many far-reaching and serious consequences.7  The golf-ball sized tumor 
discovered in a sensitive area of his brain came as a shock to the subject.8  
Disclosure of the discovery caused him to lose his health insurance when he 
 
 1. U2, I Still Haven’t Found What I’m Looking For, on THE JOSHUA TREE (Universal Island 
Records 1987). 
 2. See, e.g., U.S. Nat’l Libr. of Med., MedlinePlus Medical Encyclopedia, Head MRI, at 
www.nlm.nih.gov/medlineplus/ency/article/003791.htm (last visited May 19, 2009) 
[hereinafter MedlinePlus, Head MRI]; see also Steven Goldberg, MRIs and the Perception of 
Risk, 33 AM. J.L. & MED. 229, 231 (2007). 
 3. MedlinePlus, Head MRI, supra note 2; see also Goldberg, supra note 2, at 231. 
 4. Eric Racine & Judy Illes, Neuroethical Responsibilities, 33 CAN. J. NEUROLOGICAL SCI. 
269, 271 (2006); Eric Racine & Judy Illes, Emerging Ethical Challenges in Advanced 
Neuroimaging Research: Review, Recommendations and Research Agenda, J. EMPIRICAL 
RESEARCH ON HUMAN RESEARCH ETHICS, May 2007, at 1, 3. 
 5. Racine & Illes, Neuroethical Responsibilities, supra note 4, at 271. 
 6. Anonymous, How Volunteering for an MRI Scan Changed My Life, 434 NATURE 17, 
17 (2005). 
 7. See id. 
 8. Id. 
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and his wife were expecting their first child.9  The recommended operation 
carried a five percent risk of serious complications that could dramatically 
change his life.10 
These are just two examples of what could happen if researchers 
disclose findings.  Disclosure is not always pursued.11  Accidental discoveries 
place the researcher in what has been termed a “‘policy vacuum’”12 and 
within “Pandora’s costly box.”13  Many difficult questions are raised about 
how to best handle such discoveries:14 Does the researcher have an 
obligation to tell the participant?  Could there be liability for alerting the 
participant to a potential problem that turns out to be nothing at all?  
Currently, federal policies governing research on human subjects do not 
provide clear answers to questions surrounding such discoveries.15 
 
 9. Id. 
 10. Id.  The serious complications included the possibility of “hav[ing] to induce a massive 
stroke of [the] entire left-brain . . . [potentially leaving him] in the horrible position of being 
unable to communicate with [his] wife, [his] newborn child or [his] students[,]” and ultimately 
leading to the loss of his job.  Id. 
 11. Judy Illes et al., Discovery and Disclosure of Incidental Findings in Neuroimaging 
Research, 20 J. MAGNETIC RESONANCE IMAGING 743, 745-46 (2004) [hereinafter Illes et al., 
Discovery and Disclosure]; Judy Illes et al., Incidental Findings in Brain Imaging Research, 311 
SCIENCE 783, 783-84 (2006) [hereinafter Illes et al., Workshop Summary].  See M.J. 
Friedrich, Neuroscience Becomes Image Conscious as Brain Scans Raise Ethical Issues, 294 
JAMA 781, 782 (2005) (discussing variability among research groups when it comes to 
instituting policies and procedures for handling incidental findings); see also Frances Lawrenz 
& Suzanne Sobotka, Empirical Analysis of Current Approaches to Incidental Findings, 36 J. 
LAW, MED. & ETHICS 249, 252-55 (2008) (exploring differences in addressing incidental 
findings among federal documents, professional society and university documents, as well as 
web-posted consent forms). 
 12. Erika Check, Brain-Scan Ethics Come Under the Spotlight, 433 NATURE 185 (2005) 
(quoting participant at January 2005 U.S. National Institutes of Health workshop, “Detection 
and Disclosure of Incidental Findings in Neuroimaging Research”).  See NAT’L INST. 
NEUROLOGICAL DISORDERS & STROKE, DETECTION AND DISCLOSURE OF INCIDENTAL FINDINGS IN 
NEUROIMAGING RESEARCH, Jan. 6-7, 2005, at www.ninds.nih.gov/news_and_events/ 
proceedings/ifexecsummary.htm (last visited May 19, 2009) [hereinafter PROCEEDINGS ON 
INCIDENTAL FINDINGS] (meeting summary indicating the need for standards governing the 
disclosure of incidental findings to research participants). 
 13. Judy Illes, ‘Pandora’s Box’ of Incidental Findings in Brain Imaging Research, 2 NATURE 
CLINICAL PRACTICE NEUROLOGY 60, 60 (2006) (citing Robert I. Grossman & James L. Bernat, 
Incidental Research Imaging Findings: Pandora’s Costly Box, 62 NEUROLOGY 849 (2004)). 
 14. See id.; see also Illes et al., Workshop Summary, supra note 11, at 784. 
 15. See 45 C.F.R. §§ 46.101 – 46.409 (2008); see Jennifer J. Kulynych, The Regulation 
of MR Neuroimaging Research: Disentangling the Gordian Knot, 33 AM. J.L. & MED. 295, 314 
(2007); see also Henry S. Richardson, Incidental Findings and Ancillary-Care Obligations, 36 
J.L., MED. & ETHICS 256, 256 (2008) (stating that “the Common Rule that has shaped medical 
research ethics . . . is largely silent about what needs to be done in response to researchers’ 
positive obligations.”). 
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This comment will explore the current status of incidental findings in MRI 
research.  Part I will provide MRI research basics.  Part II will introduce the 
concept of incidental findings within the scope of MRI research.  Part III will 
discuss the limitations in policies and regulations and the resulting variety of 
institutional approaches.  Part IV will advocate for research participant 
protections and propose a new approach to funding this endeavor without 
sacrificing the research enterprise. 
PART I: MAGNETIC RESONANCE IMAGING 
The roots of MRI date back to then-cutting edge research of the 1930s 
which characterized magnetic properties of atoms.16  This concept was 
applied to molecules and eventually to tissues in a procedure known as 
nuclear magnetic resonance.17  In conjunction with echoplanar imaging, 
which enables imaging of slices of the brain, this technology became 
modern-day MRI.18  In the early 1980s, the name was formally changed 
from nuclear magnetic resonance to magnetic resonance imaging to allay 
public fears and remove any negative connotation associated with nuclear 
materials.19  In the most basic sense, MRI translates the changes observed 
when cells transition from aligning with a magnetic field to returning to “pre-
magnetized states” into images.20  Various tissue types respond differently to 
the magnetic field.21  Likewise, fMRI uses a magnetic field to detect changes 
in blood oxygen levels which accompany brain activity.22  Specific areas of 
the brain use more oxygen than others to perform certain tasks.23  Under 
 
 16. Goldberg, supra note 2, at 230.  For an excellent summary of the history of MRI 
within the context of other imaging types, see Stacey A. Tovino, Imaging Body Structure and 
Mapping Brain Function: A Historical Approach, 33 AM. J.L. & MED. 193 (2007); Laura 
Stephens Khoshbin & Shahram Khoshbin, Imaging the Mind, Minding the Image: An Historical 
Introduction to Brain Imaging and the Law, 33 AM. J.L. & MED. 171 (2007). 
 17. Goldberg, supra note 2, at 230. 
 18. Khoshbin & Khoshbin, supra note 16, at 180. 
 19. Id.; see also Goldberg, supra note 2, at 231-33. 
 20. Joseph H. Baskin et al., Is a Picture Worth a Thousand Words? Neuroimaging in the 
Courtroom, 33 AM. J.L. & MED. 239, 248 (2007); see also Laurence R. Trancredi & Jonathan 
D. Brodie, The Brain and Behavior: Limitations in the Legal Use of Functional Magnetic 
Resonance Imaging, 33 AM. J.L. & MED. 271, 274 (2007). 
 21. Baskin et al., supra note 20, at 248; see also Trancredi & Brodie, supra note 20, at 
277 (discussing how the presence of oxyhemoglobin and deoxyhemoglobin in tissues affects 
the magnetic field). 
 22. Khoshbin & Khoshbin, supra note 16, at 180. 
 23. See Marcus E. Raichle, Behind the Scenes of Functional Brain Imaging: A Historical 
and Physiological Perspective, 95 PROCEEDINGS OF THE NAT’L ACAD. OF SCI. 765, 765 (1998) 
(noting that brain activity is characterized by changes in local blood flow, which is 
accompanied by changes in oxygen consumption); Khoshbin & Khoshbin, supra note 16, at 
180 (“The underlying principle here is that neurons, when activated, convert oxyhemoglobin to 
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this premise, researchers have set out to link areas of the brain activated 
with various cognitive tasks and emotions.24  Researchers will tackle more 
and more complex brain functions and emotions,25 armed with improved 
technology—stronger magnets and combined imaging techniques.26  Better 
images, in turn, may enable researchers to see more detail and ultimately 
increase the number of accidental discoveries in MRI research.27 
A. The MRI Research Participant Experience 
For the research participant, MRI is non-invasive and usually harmless.28  
No long-term adverse effects have occurred from MRI scanning.29  Before 
the procedure, participants are screened for metal—due to the use of strong 
magnets, people with metal implants are ineligible for the procedure.30  The 
participant then lies flat on her back with her head resting on a helmet-like 
coil.31  Next, the participant is moved into the bore of the scanner with the 
lower body remaining outside of the scanner.32  During the scan, all others 
must remain outside of the room.33  Participants must lie motionless for the 
duration of the scan and will hear loud buzzing and clicking noises.34 
 
deoxyhemoglobin as they utilize oxygen, which can be detected by MRI to indicate an increase 
in neuronal activity when compared to surrounding tissues.”) (internal citation omitted). 
 24. Goldberg, supra note 2, at 231; Baskin et al., supra note 20, at 254-257, 264-66 
(discussing research efforts to localize brain areas responsible for cognitive functions and 
development, lying, antisocial behavior, and psychopathy). 
 25. See, e.g., Tina Hesman Saey, In the Brain, Justice Is Served from Many Parts: Imaging 
Study Reveals Variation in Brain Activity Depending on the Severity of Punishment a Person 
Decides, SCIENCE NEWS WEB EDITION, Dec. 10, 2008, at www.sciencenews.org/view/generic/ 
id/39239/title/In_the_brain_justice_is_served_from_many_parts (last visited May 19, 2009) 
(describing a recent study using fMRI that indicated that emotion plays a role in making legal 
determinations regarding the punishment that an individual should receive). 
 26. Khoshbin & Khoshbin, supra note 16, at 180-81. 
 27. John H. Stone, Incidentalomas — Clinical Correlation and Translational Science 
Required, 354 NEW ENG. J. MED. 2748, 2749 (2006). 
 28. MedlinePlus, Head MRI, supra note 2; Jennifer Kulynych, Legal and Ethical Issues in 
Neuroimaging Research: Human Subjects Protection, Medical Privacy, and the Public 
Communication of Research Results, 50 BRAIN & COGNITION 345, 351 (2002). 
 29. MedlinePlus, Head MRI, supra note 2. 
 30. Id.  No metal objects are allowed in the room.  People with metallic implants, such as 
artificial joints, heart valves, or brain aneurysm clips, will not be eligible.  Id.; see also 
University Institutional Review Board, Informed Consent Document for Research, Oct. 30, 
2007 (on file with author) [hereinafter University Consent]. 
 31. MedlinePlus, Head MRI, supra note 2. 
 32. Id.; University Consent, supra note 30. 
 33. See MedlinePlus, Head MRI, supra note 2; see also University Consent, supra note 
30.  Those operating the scanner usually watch from an adjoining room, maintaining contact 
with the participant through an intercom system.  MedlinePlus, Head MRI, supra note 2. 
 34. University Consent, supra note 30. 
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Researchers may take two types of scans: anatomical or functional.35  
An anatomical scan will show brain structures.  Researchers wishing to 
observe brain function will also take fMRI scans while the participant 
performs certain mental tasks.36  Depending on the type of study, the 
scanner may also have equipment for presenting visual or auditory stimuli.37  
Participants may be asked to respond to the stimuli using a hand 
controller.38  Eye movement may be monitored with an eye tracking 
device.39  The fMRI scans generated during these tasks show areas of 
activation hypothetically related to the tasks performed.40  However, there is 
some debate as to whether observable activity within specific areas of the 
brain can be reasonably tied to these tasks; for example, the observed areas 
of activation may in fact be caused by sensations associated with 
participating in the scan.41 
fMRI research may be classified as having “minimal risk” to subjects.42  
Minimal risk means risk in which “the probability and magnitude of harm or 
discomfort . . . are not greater in and of themselves than those ordinarily 
encountered in daily life or during the performance of routine physical or 
psychological examinations or tests.”43  During a scan, the risks include 
potentially acute discomfort and psychological distress from lying prone in 
the confined gantry of the MRI scanner, acoustic noise, which in some 
scanning procedures may cause hearing loss without the use of ear 
protection, and the possibility of serious physical injury if the subject and the 
nearby environment are not properly screened for metal implants or 
objects.44 
 
 35. Id. 
 36. Id. 
 37. See id. 
 38. See id. 
 39. University Consent, supra note 30. 
 40. See Trancredi & Brodie, supra note 20, at 280. 
 41. See Id.; see also Baskin et al., supra note 20, at 249. 
 42. Kulynych, supra note 28, at 351. 
 43. 45 C.F.R. § 46.102(i) (2006). 
 44. Kulynych, supra note 28, at 351-52 (internal citations omitted).  “[A]dverse 
consequences may be infrequent, but they can and do occur, as evidenced by the recent 
tragic death of a young patient struck by a metal canister during a routine MRI scan.”  Id. at 
352 (internal citations omitted). 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
418 SAINT LOUIS UNIVERSITY JOURNAL OF HEALTH LAW & POLICY [Vol. 2:413 
B. The Future of Functional Magnetic Resonance Imaging Research 
In its second decade of existence, use of fMRI has thrived.45  It is 
estimated that approximately 30,000 research participants have been 
included in fMRI studies between 1991 and 2001.46  This brain imaging 
technique represents one of the more recent developments of ever-evolving 
attempts to look inside the brain.47  Science will continue to build upon it.48  
The 2007 Symposium Issue of the American Journal of Law & Medicine was 
dedicated to legal and ethical issues in brain imaging.49  Like methods such 
as phrenology, Positron Emission Tomography (PET), and Single-Photon 
Emission Computed Tomography (SPECT) before, fMRI also raises important 
legal and ethical questions regarding which conclusions can be properly 
drawn from the techniques.50  Many of these questions are framed in the 
American Journal of Law & Medicine Symposium Issue: Can measured brain 
activity provide evidence of complex mental functions such as bias or 
feelings of guilt?51  What is the proper role of brain imaging in 
demonstrating incapacity through brain structure and deterioration?52  Might 
imaging provide insight to subjective experiences such as the perception of 
pain?53  Researchers look to MRI and fMRI to provide answers to such 
questions and further understand the brain.  The resulting increase in the 
number of studies involving these types of scans will likely increase the 
chance of encountering accidental discoveries like those previously 
described in the Introduction.54 
 
 45. Friedrich, supra note 11, at 781; see Judy Illes et al., Ethical and Practical 
Considerations in Managing Incidental Findings in Functional Magnetic Resonance Imaging, 
50 BRAIN & COGNITION 358, 364 (2002) [hereinafter Illes et al., Ethical and Practical 
Considerations] (identifying approximately 3,500 fMRI studies published between 1991 and 
2001). 
 46. Id. 
 47. See generally Tovino, supra note 16 (describing the history of neuroimaging). 
 48. See Khoshbin & Khoshbin, supra note 16, at 180-81 (explaining upcoming advances 
in neuroimaging techniques). 
 49. See generally George J. Annas, Foreword: Imagining a New Era of Neuroimaging, 
Neuroethics, and Neurolaw, 33 AM. J. L. & MED. 163 (2007). 
 50. See Tovino, supra note 16, at 215-228. 
 51. Khoshbin & Khoshbin, supra note 16, at 186-87; Baskin et al., supra note 20, at 
264-69. 
 52. Baskin et al., supra note 20, at 250-54 (discussing how brain imaging can be used to 
demonstrate incapacity and deterioration). 
 53. Adam J. Kolber, Pain Detection and the Privacy of Subjective Experience, 33 AM. J.L. 
& MED. 433, 433-34, 447-49 (2007). 
 54. See Introduction, supra. 
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PART II: INCIDENTAL FINDINGS 
Incidental findings are broadly defined as an unexpected discovery 
either outside the area of interest (in the clinical context)55 or unrelated to 
the original purpose of the inquiry (in the research context).56  Studies 
document incidental findings in a variety of settings.57  This comment will 
focus only on the unique issues surrounding incidental findings in MRI 
neuroimaging studies performed by non-physician researchers.  In this 
context, the definition of incidental findings is limited to any finding 
unrelated to the original purpose of the scan.58  While much of the research 
performed examines brain function through fMRI, the studies usually also 
include a series of anatomical scans.59  Incidental findings in MRI research 
most likely stem from the structural images of the brain (e.g., tumors); 
however, there is potential for functional images to generate incidental 
findings as well.  Researchers note that it is “premature to attempt to identify 
incidental findings” in fMRI.60 
A. Incidence 
Estimates of how often one may expect to encounter incidental findings 
vary.  In 1999, the first study looking for incidental findings in healthy or 
asymptomatic volunteers was conducted.61  The researchers retrospectively 
analyzed the brain MRI scans previously obtained from healthy controls in 
other experiments.62  Most of the 1,000 scans were normal; 18% of scans 
 
 55. Roberto Iezzi et al., Extravascular Incidental Findings at Multislice CT Angiography of 
the Abdominal Aorta and Lower Extremity Arteries: A Retrospective Review Study, 32 
ABDOMINAL IMAGING 489, 489 (2007). 
 56. Illes et al., Workshop Summary, supra note 11, at 783. 
 57. See, e.g., Brian Van Ness, Genomic Research and Incidental Findings, 36 J.L., MED. 
& ETHICS 292, 293-94 (2008) (incidental findings in genomic research may include the 
“discovery of misattributed paternity” or gene variations which might carry risk for disease such 
as BRCA1); Mikael Hellström et al., Extracolonic and Incidental Findings on CT Colonography 
(Virtual Colonoscopy), 182 AM. J. ROENTGENOLOGY 631, 631 (2002) (reporting twenty-three 
percent of CT colonography scans reviewed potentially showed clinically significant findings in 
the organs surrounding the colon); Jeffrey Mueller et al., Cardiac CT Angiography After 
Coronary Bypass Surgery: Prevalence of Incidental Findings, 189 AM. J. ROENTGENOLOGY 414 
passim (2007) (retrospective review of cardiac CT scans found previously unnoticed anomalies 
in the lungs and abdomen). 
 58. Illes et al., Workshop Summary, supra note 11, at 783. 
 59. University Consent, supra note 30. 
 60. Illes et al., Workshop Summary, supra note 11, at 784. 
 61. Gregory L. Katzman et al., Incidental Findings on Brain Magnetic Resonance Imaging 
From 1000 Asymptomatic Volunteers, 281 JAMA 36, 36 (1999). 
 62. Id. at 36-37. 
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were determined to be anomalous.63  The anomalous scans were classified 
further by apparent need for follow-up:64 15.1% required no follow-up; 
1.8% required routine referral; 1.1% required urgent referral; none were 
classified as requiring immediate care.65  Subsequent studies confirm 
incidental findings in healthy volunteers; however, the incidence ranges from 
5% to 47%.66 
Incidental findings are not limited to any specific age, race, or gender.67  
One study reported incidental findings in 13% of the sixty healthy volunteers 
ages 10 to 21,68 though none of these discoveries amounted to anything of 
clinical significance.69  In contrast, another study found that incidental 
findings among the youngest portion of the study group (mean age 25.5 
years) more often required urgent referral (three of the four incidental 
findings)70 compared to the older portion (mean age 75.5 years) in which 
none of the scans required more than routine referral.71 
One limitation of these analyses is the retrospective use of scans from 
other studies.72  The original studies from which the scans were obtained are 
not uniform; they differ in sample size, population, strength of MRI scan, 
and type of scan viewed.73  This variance makes it difficult to reconcile the 
 
 63. Id. at 37. 
 64. Id.  Examples of incidental findings requiring no follow-up included sinusitis and 
normal age-related changes.  Incidental findings requiring routine referral included possible 
demyelinating disease and pineal cysts.  Incidental findings requiring urgent follow up 
included low-grade tumors and aneurysm.  Id. 
 65. Id. 
 66. A 2004 study by Judy Illes et al. reviewed 151 MRI scans and found an overall 
prevalence of 47% containing incidental findings.  Judy Illes et al., Ethical Consideration of 
Incidental Findings on Adult Brain MRI in Research, 62 NEUROLOGY 888-89 (2004).  A 2007 
study by Meike W. Vernooij et al. reviewed 2000 scans and determined incidental findings 
had a prevalence of 7.2%.  Meike W. Vernooij et al., Incidental Findings on Brain MRI in the 
General Population, 357 NEW ENG. J. MED. 1821, 1821-23 (2007). 
 67. See, e.g., Surya N. Gupta & Brook Belay, Intracranial Incidental Findings on Brain MR 
Images in a Pediatric Neurology Practice: A Retrospective Study, 264 J. NEUROLOGICAL SCI. 
34, 35 (2007). 
 68. Sanjiv Kumra et al., Ethical and Practical Considerations in the Management of 
Incidental Findings in Pediatric MRI Studies, 45:8 J. AM. ACAD. CHILD ADOLESCENT PSYCHIATRY 
1000, 1002 (2006). 
 69. Id. at 1002-03. 
 70. Illes et al., supra note 66, at 889. 
 71. Id. 
 72. See ANN ASCHENGRAU & GEORGE R. SEAGE III, ESSENTIALS OF EPIDEMIOLOGY IN PUBLIC 
HEALTH 263 (2d ed. 2008) (discussing bias as an issue that comes up in retrospective review 
of scans). 
 73. See Trancredi & Brodie, supra note 20, at 280-83 (discussing reliability and 
reproducibility of fMRI results); see also Baskin et al., supra note 20, at 249 (discussing 
limitations inherent in comparing scans from different scanners). 
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data to pinpoint an exact incidence in the general population beyond 
revealing some likelihood of discovering a brain anomaly in healthy 
volunteers.  Further, 
[t]here are limits to the ‘objectivity’ of neuroimaging.  Brain imaging is the 
product of a complex set of techniques, subjective decisions, technical 
choices, and informed interpretations.  Scientists, technicians, and clinicians 
decide the level of detail they will use to scan the brain.  They must 
determine what types of imaging should be ordered, how thick or thin the 
slices should be, the degree of clarity, the difference in contrast between 
types of tissue, and how the signal should be filtered from background 
noise.74 
Thus, the researchers will likely optimize certain aspects of the scans to serve 
their research purposes.  These settings may be incongruent with ideal 
settings for diagnostic purposes in a clinical setting. 
B. The Problem of False Positives 
Equally worrisome are the incidental findings that turn out to be 
unimportant.  These numbers may be directly related to the size and 
inclusion criteria for the study population and type and strength of scan.75  
While the early detection of serious problems can improve outcomes, false 
positives present a serious burden both in clinical and research settings.  
One doctor noted the incidental discovery of a renal mass “ruined the 
patient’s peace of mind and diverted [the] focus from the otherwise clear 
path to health.”76  The possible presence of brain anomalies is countered by 
the occurrence of false positives which may trigger a “cascade effect”—
riskier, more expensive, stressful tests are performed only to discover there is 
no problem.77  A researcher noted that follow-up on asymptomatic tumors is 
both expensive and stressful.78  For example, once a suspect mass is found, 
annual MRI scans are usually performed for two to three years to assess 
growth and monitor changes.79  “If this were done for all persons 
incidentally found to have meningiomas, many MRI examinations would be 
performed in otherwise healthy asymptomatic persons”80 at a substantial 
cost.  Similarly, it can be very distressing to receive news of an incidental 
finding.  “[T]he provision of a diagnosis of a structural anomaly without 
 
 74. Baskin et al., supra note 20, at 249. 
 75. See Mueller et al., supra note 57, at 416-18 (discussing how incidence is affected by 
different study variables). 
 76. Stone, supra note 27, at 2748. 
 77. Goldberg, supra note 2, at 236 (internal citations omitted). 
 78. Vernooij et al., supra note 66, at 1826. 
 79. Id. 
 80. Id. 
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some type of immediate intervention or treatment resulting in resolution of 
the problem [is] problematic because the disclosure [may] generate[] 
anxiety . . . .”81 
As brain imaging technology improves, scans will likely detect 
increasingly precise and smaller-sized findings.82  At what point do the 
findings become significant enough to warrant disclosure?83  With the 
continuing improvement of scanning technologies and their increased use in 
research settings, researchers will encounter more incidental findings and 
must determine when they warrant disclosure based on factors such as size 
and organ involved.84 
Perhaps more persuasive than incidence studies is a recent survey of 
researcher experiences.  When asked whether they had encountered 
incidental findings in their studies, eighty-two percent of researchers 
responded that they had. 85  Incidental findings are a very real possibility 
confronting non-physician researchers using MRI regardless of the type of 
research or the sample used.  The findings may require urgent care or 
nothing at all; however, researchers must be cognizant of this possibility and 
aware of the implications. 
PART III: APPROACHES TO INCIDENTAL FINDINGS 
A. Regulations and Obligations 
Regulations for MRI research come from many sources, though together 
remain “insufficient in some respects and inefficiently duplicative in 
others.”86  Most applicable to the participant experience is the U.S. 
Department of Health and Human Services’ Common Rule.87  These 
regulations aim to protect research participants by setting standards for 
obtaining informed consent and institutional self-governance through 
Institutional Review Boards (IRB).88  The IRB is charged with ensuring 
research protocols do not overlook the best interests of the participants in 
research endeavors.89  The Common Rule applies to all federally funded 
research, but its reach is “extended considerably in practice” through 
 
 81. Kumra et al., supra note 68, at 1003. 
 82. Stone, supra note 27, at 2748-49. 
 83. See id. at 2748. 
 84. See id. at 2748-49. 
 85. See Illes et al., Discovery and Disclosure, supra note 11, at 744 (surveying authors of 
peer-reviewed MRI studies in U.S. and abroad from 1999-2001). 
 86. Kulynych, supra note 15, at 296. 
 87. See generally 45 C.F.R. §§ 46.101 – 46.409 (2008). 
 88. Id. 
 89. Id. 
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voluntary application.90  Further, state laws and institutional policies may 
impose additional regulations over and above these federal regulations.91 
In the context of incidental findings, the Common Rule “is largely silent 
about what needs to be done in response to researchers’ positive 
obligations.”92  Instead, researcher obligations with respect to incidental 
findings may be derived from other sources such as contracts, general 
beneficence, or professional responsibility.93  It is established that informed 
consent documents can bind researchers to the obligations therein.94  The 
question remains whether, absent specific language addressing incidental 
findings in the informed consent document, the researcher has any resulting 
duty.  While the philosophical underpinnings of potential researcher duties 
are well beyond the scope of this comment, some duties are recognized, 
stemming from the principle of general beneficence and the special 
relationship between researcher and participant.95  Institutions choosing to 
address incidental findings do so without elucidating the source of the duty. 
B. Institutional Approaches 
In the absence of explicit regulatory requirements for incidental findings, 
some research institutions have begun to implement their own policies.96  
While some research protocols incorporate these unexpected discoveries, 
 
 90. BARRY R. FURROW ET AL., BIOETHICS: HEALTH CARE LAW AND ETHICS 420 (6th ed. 2008). 
 91. Kulynych, supra note 28, at 351.  For example, New York has enacted state 
regulations which essentially extend federal IRB and informed consent requirements to all 
research that might not otherwise be subject to federal regulations.  Similarly, the California 
Protection of Human Subjects in Medical Experimentation Act creates the Experimental 
subject’s bill of rights which also extends to protect participants in experiments not covered by 
federal law.  Id. at 349; N.Y. PUB. HEALTH LAW §§2441-2446 (McKinney 2007); CAL. HEALTH & 
SAFETY CODE §§ 24171-24179.5 (West 2007). 
 92. Richardson, supra note 15, at 256. 
 93. Franklin G. Miller et al., Incidental Findings in Human Subjects Research: What Do 
Investigators Owe Research Participants?, 36 J.L., MED. & ETHICS 271, 272 (2008). 
 94. Id.  See Grimes v. Kennedy Krieger Institute, Inc., 782 A.2d 807, 858 (Md. 2001) 
(holding, in part, “that informed consent agreements in nontherapeutic research projects, 
under certain circumstances can constitute contracts; and that, under certain circumstances, 
such research agreements can, as a matter of law, constitute ‘special relationships’ giving rise 
to duties, out of the breach of which negligence actions may arise.”); see also Alan C. 
Milstein, Research Malpractice and the Issue of Incidental Findings, 36 J.L., MED. & ETHICS 
356, 358 (2008). 
 95. Miller et al., supra note 93, at 272; Grimes, 782 A.2d at 858; Milstein, supra note 
94, at 358-59; Richardson, supra note 15, at 256-57. 
 96. Illes et al., Discovery and Disclosure, supra note 11, at 745 (revealing “substantial 
procedural variability across research units for . . . detecting and communicating abnormal 
findings to [subjects]”). 
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there is no regulation of their uniform disposal.97  In fact, there is no 
requirement for researchers to address them at all.98  Further, “there 
appears to be little guidance available on what researchers should do” 
when confronted with incidental findings.99 
A team lead by Judy Illes examined fMRI research protocols in a 2004 
study.100  The authors surveyed researchers who had published peer-
reviewed fMRI research studies between 1991 and 2002.101  The 
responding cohort consisted of seventy-four investigators from the United 
States and abroad who conduct structural or functional MRI studies.102  A 
majority of the investigators conduct fewer than 500 scans per year (seventy-
one percent) with the remaining twenty-nine percent conducting 500 or 
more scans in a year.103  Eighty-two percent of the respondents reported 
having knowledge of incidental findings in their research, such as tumors, 
cysts, and malformations.104  Once incidental findings were discovered, 
there was much variation in protocols for handling incidental findings. 
53% (28/53) reported that they have standardized procedures in place for 
handling incidental findings and communicating with research participants 
in whom findings [were] discovered.  All others proceed on an ad hoc, case-
by-case basis.  Neuroradiologist involvement is an IRB requirement for 22% 
(11/49) of laboratories reporting on this question.  In laboratories in which 
neuroradiologist involvement is not required by the IRB, scans are 
nonetheless always read 13% (5/38) of the time, upon suspicious finding 
69% (26/38) of the time, and not at all 18% (7/38) of the time.105 
The study also revealed differences in “lag time”—the time between 
receiving the scan and review by a neuroradiologists—and how 
neuroradiologists are compensated for this review.106 
 
 97. Moira A. Keane, Institutional Review Board Approaches to the Incidental Findings 
Problem, 36 J.L., MED. & ETHICS 352, 352 (2008). 
 98. See id. (noting IRBs are not regulated with respect to ethical guidelines and 
regulations). 
 99. Lawrenz & Sobotka, supra note 11, at 249. 
 100. Illes et al., Discovery and Disclosure, supra note 11, at 743. 
 101. Id. 
 102. Id. at 744.  The survey was conducted via email and had an 11% response rate (81 
out of 717).  Eighty-one investigators accessed the survey, 74 of which responded to at least 
some of the survey.  Fifty-eight percent of the respondents were from the United States 
(fifteen/twenty-six).  Other countries included France, Japan, Italy, The Netherlands, Scotland, 
United Kingdom, and Sweden and represented the remaining forty-two percent (eleven/twenty-
six).  Id. 
 103. Id. 
 104. Id. at 744-45.  The survey did not specifically ask respondents to report what the 
incidental findings were, but some included the information in a comments section.  Id. 
 105. Illes et al., Discovery and Disclosure, supra note 11, at 745. 
 106. Id. 
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A more recent study by Frances Lawrenz and Suzanne Sobotka 
examined guidance documents found online for handling incidental findings 
(IFs).107  Overall they conclude 
 “Very few documents address IFs . . . .” 
 “Terms used to describe IFs are not consistent across documents.” 
 “Very few say to not disclose IFs . . . .” 
 “Very few documents recommend checking with a clinical consultant to 
evaluate whether an IF of concern appears present before disclosing 
it.”108 
C. Recommendations 
In an effort to reach a consensus in handling incidental findings in MRI 
research, professionals from a variety of backgrounds convened to discuss 
the present issues.109  The group was guided by the belief that “[a]ny future 
official recommendations on incidental findings should promote trust in 
research without unduly encumbering the scientific process.”110  All agreed 
that incidental findings must be anticipated, that institutions have protocols 
in place for incidental findings, and that these protocols are clearly 
communicated to volunteers through informed consent.111  Other 
recommendations include: 
 “[I]nclusion of a professional competent to interpret a neuroimaging 
scan for clinically significant findings.” 
 “[T]he [participant] or surrogate is first in line for disclosure of an 
incidental finding.  Communication with the [participant] or surrogate 
should be done by a qualified member of the research team: the 
Principal Investigator (PI), a neuroradiologists or physician.” 
 “The development of a database of incidental findings and an atlas of 
different types of incidental findings would be a valuable scientific 
resource.”112 
PART IV: SUGGESTIONS 
Given the current landscape and these recommendations, ignoring the 
possibility of incidental findings in MRI research is not a viable option.  
Beyond the minimum requirement of addressing incidental findings, there is 
 
 107. Lawrenz & Sobotka, supra note 11, at 249-250. 
 108. Id. at 254-55. 
 109. PROCEEDINGS ON INCIDENTAL FINDINGS, supra note 12. 
 110. Illes et al., Workshop Summary, supra note 11, at 783. 
 111. Id. at 783-84; see also supra Part III for support from ethical guidelines. 
 112. PROCEEDINGS ON INCIDENTAL FINDINGS, supra note 12. 
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“no single approach . . . [instead] a range of morally acceptable options 
exist.”113  Any option that is pursued must strike a balance between 
promoting both participant welfare and the research endeavor.114  
Institutions and the collective group of researchers conducting these types of 
studies might consider three options to achieve this balance.  First, the 
informed consent process for MRI studies should be revised to explicitly 
address incidental findings in a way that is easily understood by participants.  
Next, given truly informed consent, participants should be able to opt out of 
receiving any diagnostic tipoff regarding health.  Finally, given the 
unpredictable nature of how incidental findings could impact any one study, 
alternate sources of funding should be created that will relieve the potential 
burden on institutions of allocating money for expensive follow-up with 
participants.  Each of these suggestions will be advocated below. 
How researchers handle incidental findings may differ significantly from 
what the participants believe, regardless of the informed consent 
language.115  One survey demonstrates that participants may believe, 
despite informed consent language to the contrary, that they will be notified 
if non-physician researchers discover a potential anomaly.116  In this study, 
volunteers received survey invitations via email subsequent to participating 
in neuroimaging studies in one of two different environments: a medical 
setting (adjacent to a medical center) and non-medical setting (adjacent to 
a university psychology building).117  More than half of the 105 participants 
(51% or 40/78 from the medical setting and 63% or 17/27 in the non-
medical setting) responded they expected brain abnormalities to be detected 
if present, even though a majority of participants acknowledged physicians 
would not be reviewing the scans.118  Almost all of the participants said they 
would want to know if researchers found abnormalities of any significance 
level.119  Despite the small sample size and potentially biasing consent 
language in both settings,120 this study suggests that volunteers may not 
 
 113. Judy Illes & Vivian Nora Chin, Bridging Philosophical and Practical Implications of 
Incidental Findings in Brain Research, 36 J.L., MED. & ETHICS 298, 303 (2008). 
 114. Id. 
 115. See Matthew P. Kirschen et al., Subjects’ Expectations in Neuroimaging Research, 23 
J. MAGNETIC RESONANCE IMAGING 205 (2006). 
 116. Id. at 206. 
 117. Id. 
 118. Id. at 207. 
 119. Id. 
 120. Kirschen et al., supra note 115, at 206-07.  Medical setting consent language: “The 
investigators for this project are not trained to perform radiological diagnosis, and the scans 
performed in this study are not optimized to find abnormalities.  The investigators and [name 
of institution] are not responsible for failure to find existing abnormalities in your MRI scans.  
However, on occasion the investigator may notice a finding on an MRI scan that seems 
abnormal.  When this occurs, a neuroradiologist will be consulted as to whether the finding 
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understand the consent forms.121  The cohort, comprised mostly of students 
and academics, still believed existing abnormalities would be discovered.122  
This implicates therapeutic misconception, potentially leaving participants 
with a false sense of confidence from their participation.123  Almost none of 
the participants entered the initial MRI study for diagnostic purposes; 
however, most left assuming they had no existing brain abnormalities.124 
Given the unique status of using medical devices in non-therapeutic 
research, investigators must make absolutely sure the participants 
understand what benefits to expect.125  Institutions receiving federal research 
funding must file an assurance “it will comply with the requirements set forth 
in [the Code of Federal Regulations] policy.”126  The general requirements 
for informed consent state the researcher must “obtain[] the legally effective 
informed consent of the subject . . . under circumstances that provide the 
prospective subject . . . sufficient opportunity to consider whether or not to 
participate and that minimize the possibility of coercion or undue 
influence.”127  The form must be in “language understandable to the 
subject.”128  The rest of the section spells out the minimum basic elements of 
informed consent: purpose, description of risks, and benefits reasonably 
expected.129  The United States Department of Health and Human Services 
website provides additional guidance for interpreting the federal regulations: 
It is up to the IRB to determine in a particular instance whether some or all 
of the . . . additional elements must be included as part of the informed 
consent process for a particular study.  The IRB should make this 
determination based on the nature of the research and its knowledge of the 
local research context.  If the IRB determines that additional elements are 
appropriate to the research study, this additional information should be 
 
merits further investigation, in which case the investigator will contact you.”  Id. at 206.  Non-
medical consent language stated, “[t]his study is part of a research protocol, and is not 
intended to provide a comprehensive clinical MRI examination of the brain.  If, however, a 
potential abnormality is identified on your MRI scan, you will be immediately notified and your 
scan will be forwarded to your family physician.”  Id. 
 121. Id. at 207-08. 
 122. Id. at 207.  This literate and educated group should arguably have the best 
comprehension of consent language. 
 123. Id. at 208. 
 124. Id. at 207.  Motivations for volunteering for MRI studies include: financial 
compensation or course credit (sixty-two percent); contribute to scientific knowledge (twenty-
one percent); favor to experimenter (sixteen percent); and health concern (one percent).  Id. at 
tbl.1. 
 125. 45 C.F.R. § 46.116 (2008). 
 126. 45 C.F.R. § 46.103(a) (2008). 
 127. 45 C.F.R. § 46.116 (2008). 
 128. 45 C.F.R. § 46.116 (2008). 
 129. 45 C.F.R. § 46.116(a) (2008). 
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considered just as essential as the eight basic elements of informed consent 
described in the HHS regulations at 45 CFR 46.116(a).130 
Incidental findings raise a difficult to understand concept.  Given the 
increased potential for misunderstanding, additional precautions should be 
taken.  The Common Rule enables an IRB to require additional information 
to the consent which would “meaningfully add to the protection of the rights 
and welfare of subjects.”131  It should be inferred from these studies that the 
potential existence of brain abnormalities and knowledge about the 
institution’s policies for handling incidental findings absolutely contribute to 
“circumstances that provide the prospective subject . . . sufficient opportunity 
to consider whether or not to participate . . . . “132  The false sense of 
confidence is certainly an effect upon health that comes directly from 
participating in the research and may ultimately prevent some from seeking 
future medical treatment.  While incidental findings do not always present a 
particularly serious risk in MRI research, they do present a known risk in 
terms of incidence and volunteer misconception.133 
The incidental finding language cited in the volunteer expectation study 
was out of context of the entire form; however, one institution placed the 
incidental finding language at the end of the “Description of the 
discomforts, inconveniences, and/or risks that can be reasonably expected 
as a result of participation in this study” section.134  Moving the incidental 
finding language to a separate section may prevent confusion.  One study 
has explored different methods for improving volunteer comprehension in 
informed consent research.135  Results were inconclusive for the effect of 
multimedia and enhanced consent forms such as touch-screen interactive 
forms and PowerPoint presentations.136  Some results suggest volunteer 
understanding may be improved by having a research team member or 
neutral educator spend time explaining the consent form.137  Overall, these 
 
 130. OFFICE FOR HUMAN RESEARCH PROTECTIONS (OHRP), HHS, OHRP INFORMED CONSENT 
FREQUENTLY ASKED QUESTIONS, at www.hhs.gov/ohrp/informconsfaq.html (last visited May 19, 
2009). 
 131. 45 C.F.R. § 46.109(b) (2008) (“An IRB shall require that information given to subjects 
as part of informed consent is in accordance with § 46.116.  The IRB may require that 
information, in addition to that specifically mentioned in § 46.116, be given to the subjects 
when in the IRB’s judgment the information would meaningfully add to the protection of the 
rights and welfare of subjects.”). 
 132. 45 C.F.R. § 46.116 (2008). 
 133. See Kirschen et al., supra note 115. 
 134. University Consent, supra note 30. 
 135. James Flory & Ezekiel Emanuel, Interventions to Improve Research Participants’ 
Understanding in Informed Consent for Research: A Systematic Review, 292 JAMA 1593, 
1593-94 (2004). 
 136. Id. at 1595 tbl.1. 
 137. Id. at 1599. 
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are relatively low-cost and easily implemented options to ensure consent is 
truly informed which should be further investigated. 
Participants at the National Institute for Health discussed the possibility 
of consent forms that give volunteers the opportunity to opt-out of receiving 
any health information generated from their participation in the research.138  
To the extent it puts researchers in an “ethical conundrum” when faced with 
seemingly obvious life threatening findings, it must be reconciled with 
respect for volunteer autonomy.139  If the volunteer chooses not to find out 
about potential health problems, the other questions surrounding incidental 
findings need not be addressed.  A survey about the expectations and 
attitudes of volunteers prior to participating in research after providing a full 
picture of the risks and benefits tied to disclosing incidental findings could 
help focus options for dealing with those volunteers who still wish to be 
informed. 
While some have changed their positions on this matter,140 option 
consent forms should be implemented, thus removing the burden of 
unwanted information from volunteers’ minds and removing any difficulty a 
researcher may have in deciding whether or not to disclose information.  In 
addition to an explicit description of the current protocol for handling 
incidental findings,141 volunteers could benefit from learning of the 
prevalence of incidental findings, the risks involved with disclosure, the 
possible outcomes, and the likely outcomes.  Also, volunteers should know 
that the scans are not likely optimized for diagnosis.  The Workshop 
participants agreed it would be an unfair burden to require research labs 
take additional clinical-grade scans for the purpose of potential 
diagnosis.142 
Finally, alternate sources of funding should be considered to cover costs 
associated with participant follow-up.  While changing research protocols to 
include the potential for incidental findings will certainly increase costs, one 
important concern is which costs the researcher should cover beyond 
notification.  Referral is considered an absolute minimum, but the question 
remains whether it is sufficient to refer a participant who has no means to 
pay for necessary follow-up.143 
The potential for incidental findings is shared by all researchers 
conducting MRI studies.  Therefore, to relieve burdensome costs associated 
 
 138. Illes et al., Workshop Summary, supra note 11, at 784. 
 139. Id. (noting respect for participant “autonomy is difficult to reconcile with a Good 
Samaritan ethos.”). 
 140. Illes & Chin, supra note 113, at 303. 
 141. See discussion supra Part III. 
 142. Illes et al., Workshop Summary, supra note 11, at 784. 
 143. Illes & Chin, supra note 113, at 303-04. 
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with volunteer follow-up, one option might be to create a centralized source 
of funding.  Analogous to IOLTA accounts,144 money received for qualified 
research could be held in trust, with interest allocated to a centralized pool 
which would fund necessary participant follow-up costs.  Qualified research 
might include neuroimaging studies in which researchers have protocols in 
place for reviewing scans and notifying participants of incidental findings.  
This would both relieve researchers of the dilemma posed by under- and 
uninsured volunteers who potentially need urgent follow-up care and 
minimize budget increases for handling incidental findings. 
CONCLUSION 
The increased prominence of MRI in research settings means that an 
increasing number of researchers will be faced with incidental findings.  
Incidental findings place both researchers and participants in a difficult 
situation, introducing potentially urgent medical conditions to otherwise 
unrelated research.  To continue MRI research, protocols should anticipate 
incidental findings and recognize the unique problems surrounding their 
discovery.  This possibility may necessitate heightened attention in the 
informed consent process.  Once the potential for incidental findings is 
properly explained in the consent, participants should have the option to not 
be informed.  Finally, the increased costs relating to volunteer follow-up 
should not be shouldered by individual institutions.  Given the nature of 
incidental findings, institutions should look for ways to share costs through 
pooled participant follow-up funds.  This will help ensure that the scientific 
pursuit is not sidelined for a potentially medically significant incidental 
finding. 
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